8194460 Who owns Clvs? [Solved]

Who owns Clvs?

Top 10 Owners of Clovis Oncology Inc

Stockholder Stake Shares owned
The Vanguard Group, Inc. 6.90% 9,820,571
BlackRock Fund Advisors 5.82% 8,284,149
Palo Alto Investors LP 2.81% 3,997,826
Geode Capital Management LLC 1.56% 2,212,612

Similarly, Will Clvs stock go up?

During the day the stock fluctuated 17.49% from a day low at $2.63 to a day high of $3.09. The price has risen in 6 of the last 10 days and is up by 75% over the past 2 weeks.

Predicted Opening Price for Clovis Oncology of Tuesday, April 5, 2022.

Fair opening price April 5, 2022 Current price
$2.82 $2.73 (Undervalued)

Is Clovis Oncology a good stock? The stock is significantly undervalued and this year could unlock significant near-term value in the form of ATHENA trial data. Long-term (3-4 years) first price target = $40 (15x potential).

Thereof, Who founded Clovis Oncology?

Clovis Oncology is an American pharmaceutical company which mainly markets products for treatment in oncology. Clovis was founded in 2009 and is headquartered in Boulder, Colorado.

Clovis Oncology.

Type Public
Founder Patrick Mahaffy
Headquarters Boulder, Colorado , U.S.
Revenue $165 Million(2020)
Number of employees 429

What does Clovis Oncology do?

Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Does CLV pay dividends?

CLOVIS ONCOLOGY (NASDAQ: CLVS) does not pay a dividend.

When did Clovis Oncology go public?

In addition, the underwriters have a 30-day option to purchase up to an additional 1,500,000 shares of common stock from Clovis Oncology to cover over-allotments, if any. Shares of Clovis Oncology’s common stock will trade on the NASDAQ Global Select Market under the symbol « CLVS » beginning on November 16, 2011.

Who is the CEO of Clovis Oncology?

President/CEO/Co-Founder, Clovis Oncology Inc.

Join TheMoney.co community and don’t forget to share this post !

Quitter la version mobile